about
Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western KenyaImmunoregulation in human malaria: the challenge of understanding asymptomatic infectionCD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection.Genetic immunisation by liver stage antigen 3 protects chimpanzees against malaria despite low immune responses.Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interfaceCross-protection between attenuated Plasmodium berghei and P. yoelii sporozoitesNatural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection modelA Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.Mice deficient in interleukin-4 (IL-4) or IL-4 receptor alpha have higher resistance to sporozoite infection with Plasmodium berghei (ANKA) than do naive wild-type mice.Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.Transformation of sporozoites into early exoerythrocytic malaria parasites does not require host cellsA combined transcriptome and proteome survey of malaria parasite liver stages.Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites.Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicityIFNγ/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children.An experimental model to study tuberculosis-malaria coinfection upon natural transmission of Mycobacterium tuberculosis and Plasmodium bergheiGamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.Class II-restricted protective immunity induced by malaria sporozoites.Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines.Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF.
P2860
Q24797832-92B788FD-3B04-4CF9-9F42-42AF35041153Q26775212-786FF5DD-C407-409A-B4F4-F298A54D5D89Q30555356-14BD82ED-6A7B-4911-A983-91884F7B416FQ33351936-93E163D8-179B-482E-9ED9-630C3387A98BQ33830767-A39E1D31-97EC-499A-9453-23DB77AA18E8Q34204920-78852BAC-92EB-4558-A3BE-94808B375DA6Q34460946-2A81FE5B-3570-4E31-A7DC-7F635655A735Q35925784-5F72F883-8586-4B23-BFFB-198120B260BBQ36226846-688E5178-9706-4F5A-9BC5-49ACE10C25FBQ36285998-BFAE67D8-B3E0-4578-BF12-84E31CF9A54EQ36370678-4988558D-113C-4DBC-BADE-A314D4E316A3Q36423509-B4C819CE-223D-4E51-AA32-4796DB704247Q36702125-ABA207DC-B88D-4E87-8525-2CE25A4C17B9Q37235262-F5AAD88B-1B03-418A-B679-4859F8775633Q37458864-CEF4E7E2-67AE-4B42-AF3E-01C9E54CEBAFQ37708520-7A956FC5-F0E2-4D6B-81B7-538CC1D130C3Q40015116-6E98C44D-A595-4359-BB8D-06D9C0F5FBBAQ41825623-2AD436CF-54C0-448A-9DC2-AEB7A4D63687Q44163139-0087D57F-ED04-47E3-8E6D-FD9B889163AAQ44170879-8A263A20-E349-4AA6-BDF5-2D579D0C5677Q47904591-EA0A533A-3146-4D5B-BE47-B4D5A2711A99Q51629833-C7F4CEBE-F843-4E6F-B369-D92937F7476F
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Malaria vaccines-targeting infected hepatocytes.
@en
Malaria vaccines-targeting infected hepatocytes.
@nl
type
label
Malaria vaccines-targeting infected hepatocytes.
@en
Malaria vaccines-targeting infected hepatocytes.
@nl
prefLabel
Malaria vaccines-targeting infected hepatocytes.
@en
Malaria vaccines-targeting infected hepatocytes.
@nl
P2860
P356
P1433
P1476
Malaria vaccines-targeting infected hepatocytes.
@en
P2093
P2860
P2888
P304
P356
10.1038/81315
P407
P577
2000-11-01T00:00:00Z